Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 758

1.

Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.

Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T, Emrich HM.

Pharmacopsychiatry. 2002 Mar;35(2):57-61.

PMID:
11951146
2.

Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

Müller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T, Emrich HM.

J Clin Psychiatry. 2003 Apr;64(4):459-65.

PMID:
12716250
3.

Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.

Müller-Vahl KR, Koblenz A, Jöbges M, Kolbe H, Emrich HM, Schneider U.

Pharmacopsychiatry. 2001 Jan;34(1):19-24.

PMID:
11229617
4.

Ondansetron treatment in patients with Tourette's syndrome.

Toren P, Laor N, Cohen DJ, Wolmer L, Weizman A.

Int Clin Psychopharmacol. 1999 Nov;14(6):373-6.

PMID:
10565805
5.

Cannabinoids reduce symptoms of Tourette's syndrome.

Müller-Vahl KR.

Expert Opin Pharmacother. 2003 Oct;4(10):1717-25. Review.

PMID:
14521482
6.

Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial.

Gilbert DL, Sethuraman G, Sine L, Peters S, Sallee FR.

Neurology. 2000 Mar 28;54(6):1310-5.

PMID:
10746603
7.

Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study.

Toren P, Weizman A, Ratner S, Cohen D, Laor N.

J Clin Psychiatry. 2005 Apr;66(4):499-503.

PMID:
15816793
8.

Influence of family history on clinical expression of Tourette's syndrome.

Lichter DG, Dmochowski J, Jackson LA, Trinidad KS.

Neurology. 1999 Jan 15;52(2):308-16.

PMID:
9932949
9.

Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.

Bruggeman R, van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA.

J Clin Psychiatry. 2001 Jan;62(1):50-6.

PMID:
11235929
10.

Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.

Silver AA, Shytle RD, Philipp MK, Wilkinson BJ, McConville B, Sanberg PR.

J Clin Psychiatry. 2001 Sep;62(9):707-14.

PMID:
11681767
11.

Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.

Hoekstra PJ, Minderaa RB, Kallenberg CG.

J Clin Psychiatry. 2004 Apr;65(4):537-42.

PMID:
15119917
12.

The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

Singer HS, Brown J, Quaskey S, Rosenberg LA, Mellits ED, Denckla MB.

Pediatrics. 1995 Jan;95(1):74-81.

PMID:
7770313
13.

Cannabinoids for Tourette's Syndrome.

Curtis A, Clarke CE, Rickards HE.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006565. doi: 10.1002/14651858.CD006565.pub2. Review.

PMID:
19821373
14.

Paroxetine treatment of episodic rages associated with Tourette's disorder.

Bruun RD, Budman CL.

J Clin Psychiatry. 1998 Nov;59(11):581-4.

PMID:
9862603
15.

The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder.

Cath DC, Spinhoven P, van de Wetering BJ, Hoogduin CA, Landman AD, van Woerkom TC, Roos RA, Rooijmans HG.

J Clin Psychiatry. 2000 Jul;61(7):505-13.

PMID:
10937609
16.

A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome.

Kurlan R, Como PG, Deeley C, McDermott M, McDermott MP.

Clin Neuropharmacol. 1993 Apr;16(2):167-72.

PMID:
8477412
17.

Risperidone as a treatment for Tourette's syndrome.

Bruun RD, Budman CL.

J Clin Psychiatry. 1996 Jan;57(1):29-31.

PMID:
8543544
18.

A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome.

Peterson BS, Zhang H, Anderson GM, Leckman JF.

J Clin Psychopharmacol. 1998 Aug;18(4):324-31.

PMID:
9690699
19.

Clonidine treatment of Gilles de la Tourette's syndrome.

Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ.

Arch Gen Psychiatry. 1991 Apr;48(4):324-8.

PMID:
2009034
20.

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ.

J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1140-6.

PMID:
7559307

Supplemental Content

Support Center